373 related articles for article (PubMed ID: 24276217)
1. Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study.
Weinstein G; Beiser AS; Choi SH; Preis SR; Chen TC; Vorgas D; Au R; Pikula A; Wolf PA; DeStefano AL; Vasan RS; Seshadri S
JAMA Neurol; 2014 Jan; 71(1):55-61. PubMed ID: 24276217
[TBL] [Abstract][Full Text] [Related]
2. Plasma Brain-Derived Neurotropic Factor Levels Are Associated with Aging and Smoking But Not with Future Dementia in the Rotterdam Study.
Galle S; Licher S; Milders M; Deijen JB; Scherder E; Drent M; Ikram A; van Duijn CM
J Alzheimers Dis; 2021; 80(3):1139-1149. PubMed ID: 33646145
[TBL] [Abstract][Full Text] [Related]
3. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.
Lieb W; Beiser AS; Vasan RS; Tan ZS; Au R; Harris TB; Roubenoff R; Auerbach S; DeCarli C; Wolf PA; Seshadri S
JAMA; 2009 Dec; 302(23):2565-72. PubMed ID: 20009056
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.
van Himbergen TM; Beiser AS; Ai M; Seshadri S; Otokozawa S; Au R; Thongtang N; Wolf PA; Schaefer EJ
Arch Neurol; 2012 May; 69(5):594-600. PubMed ID: 22213409
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Environmental Correlates of Serum BDNF: A Descriptive Study with Plausible Implications for AD Research.
Weinstein G; Preis SR; Beiser AS; Kaess B; Chen TC; Satizabal C; Rahman F; Benjamin EJ; Vasan RS; Seshadri S
Curr Alzheimer Res; 2017; 14(7):722-730. PubMed ID: 28164772
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes.
Pase MP; Beiser AS; Himali JJ; Satizabal CL; Aparicio HJ; DeCarli C; Chêne G; Dufouil C; Seshadri S
JAMA Neurol; 2019 May; 76(5):598-606. PubMed ID: 30830207
[TBL] [Abstract][Full Text] [Related]
7. Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community.
Kaess BM; Preis SR; Lieb W; Beiser AS; Yang Q; Chen TC; Hengstenberg C; Erdmann J; Schunkert H; Seshadri S; Vasan RS; ; Assimes TL; Deloukas P; Holm H; Kathiresan S; König IR; McPherson R; Reilly MP; Roberts R; Samani NJ; Stewart AF
J Am Heart Assoc; 2015 Mar; 4(3):e001544. PubMed ID: 25762803
[TBL] [Abstract][Full Text] [Related]
8. Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.
McGrath ER; Himali JJ; Levy D; Conner SC; Pase MP; Abraham CR; Courchesne P; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
PLoS One; 2019; 14(3):e0213321. PubMed ID: 30830941
[TBL] [Abstract][Full Text] [Related]
9. Serum brain-derived neurotrophic factor and vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury: Framingham Study.
Pikula A; Beiser AS; Chen TC; Preis SR; Vorgias D; DeCarli C; Au R; Kelly-Hayes M; Kase CS; Wolf PA; Vasan RS; Seshadri S
Stroke; 2013 Oct; 44(10):2768-75. PubMed ID: 23929745
[TBL] [Abstract][Full Text] [Related]
10. Circulating ceramide ratios and risk of vascular brain aging and dementia.
McGrath ER; Himali JJ; Xanthakis V; Duncan MS; Schaffer JE; Ory DS; Peterson LR; DeCarli C; Pase MP; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
Ann Clin Transl Neurol; 2020 Feb; 7(2):160-168. PubMed ID: 31950603
[TBL] [Abstract][Full Text] [Related]
11. Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia.
Sanders AE; Wang C; Katz M; Derby CA; Barzilai N; Ozelius L; Lipton RB
JAMA; 2010 Jan; 303(2):150-8. PubMed ID: 20068209
[TBL] [Abstract][Full Text] [Related]
12. Serum brain-derived neurotrophic factor and risk of atrial fibrillation.
Rahman F; Himali JJ; Yin X; Beiser AS; Ellinor PT; Lubitz SA; Vasan RS; Magnani JW; McManus DD; Seshadri S; Benjamin EJ
Am Heart J; 2017 Jan; 183():69-73. PubMed ID: 27979044
[TBL] [Abstract][Full Text] [Related]
13. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy.
Westwood AJ; Beiser A; Decarli C; Harris TB; Chen TC; He XM; Roubenoff R; Pikula A; Au R; Braverman LE; Wolf PA; Vasan RS; Seshadri S
Neurology; 2014 May; 82(18):1613-9. PubMed ID: 24706014
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and post-stroke dementia: a hospital-based study from northern Iran.
Rezaei S; Asgari Mobarake K; Saberi A; Keshavarz P; Leili EK
Neurol Sci; 2016 Jun; 37(6):935-42. PubMed ID: 27071687
[TBL] [Abstract][Full Text] [Related]
16. Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia.
Yasutake C; Kuroda K; Yanagawa T; Okamura T; Yoneda H
Eur Arch Psychiatry Clin Neurosci; 2006 Oct; 256(7):402-6. PubMed ID: 16783499
[TBL] [Abstract][Full Text] [Related]
17. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
[TBL] [Abstract][Full Text] [Related]
18. Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory.
Kim A; Fagan AM; Goate AM; Benzinger TL; Morris JC; Head D;
Cogn Affect Behav Neurosci; 2015 Sep; 15(3):625-43. PubMed ID: 25784293
[TBL] [Abstract][Full Text] [Related]
19. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF.
Lim YY; Rainey-Smith S; Lim Y; Laws SM; Gupta V; Porter T; Bourgeat P; Ames D; Fowler C; Salvado O; Villemagne VL; Rowe CC; Masters CL; Zhou XF; Martins RN; Maruff P
Int Psychogeriatr; 2017 Nov; 29(11):1825-1834. PubMed ID: 28720165
[TBL] [Abstract][Full Text] [Related]
20. Val66Met polymorphism and BDNF levels in Alzheimer's disease patients in North Indian population.
Sonali N; Tripathi M; Sagar R; Vivekanandhan S
Int J Neurosci; 2013 Jun; 123(6):409-16. PubMed ID: 23270505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
